Search for Clinical Trial Results

Carbohydrate Metabolism, Inborn Errors - 23 Studies Found
Status | Study |
Recruiting |
Study Name: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS Condition: Glut1 Deficiency Syndrome Date: 2013-12-03 Interventions: Drug: GLUT1 DS |
Completed |
Study Name: Carbohydrate Intolerance Questionnaire Study Condition: Carbohydrate Intolerance Date: 2017-04-25 Interventions: Dietary Supplement: TRUTOL Glucose Tolerance Beverage A caffeine-free, non-carbonated, glucose tolerance |
Completed |
Study Name: Measuring the Glycemic Index of Pulse Based Breads Condition: Carbohydrate Intolerance Date: 2017-01-06 Interventions: Other: Bread |
Active, not recruiting |
Study Name: A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency Condition: Genetic Sucrase-Isomaltase Deficiency Date: 2016-05-18 Interventions:
|
Enrolling by invitation |
Study Name: Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS Condition: Glucose Transporter Type 1 Deficiency Syndrome Date: 2015-11-03 Interventions: Drug: UX007 UX007 is a liquid intended for oral (PO) administration. |
Recruiting |
Study Name: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) Date: 2014-01-13 Interventions: Drug: Triheptanoin Schedule A: Subjects previously treated |
Not yet recruiting |
Study Name: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) Condition:
Date: 2013-12-12 Interventions: Drug: Triheptanoin Triheptanoin (C7 oil) is a 7-carbon medium chain triglyceride. |
Not yet recruiting |
Study Name: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) Condition:
Date: 2013-12-11 Interventions: Drug: Triheptanoin Triheptanoin is a 7-carbon medium chain triglyceride |
Available |
Study Name: Post Study Continuation of C7 for G1D Condition:
Date: 2013-12-11 Interventions: Drug: Triheptanoin Other Names:
|
Recruiting |
Study Name: The Glucose Transporter Type I Deficiency (G1D) Registry Condition:
|